Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	MHC protein binding	HLA-B HLA-C MFSD6 KIR2DL1 KIR2DS4 KIR3DL1	3.08e-07	58	94	6	GO:0042287
GeneOntologyMolecularFunction	MHC class Ib protein binding	KIR2DL1 KIR2DS4 KIR3DL1	5.41e-05	16	94	3	GO:0023029
GeneOntologyMolecularFunction	MHC class Ib receptor activity	KIR2DL1 KIR2DS4 KIR3DL1	9.27e-05	19	94	3	GO:0032394
GeneOntologyMolecularFunction	transcription corepressor activity	CASP8AP2 CBX4 MED1 RUNX1T1 ARID5A NCOR2 SETD5	1.05e-04	229	94	7	GO:0003714
GeneOntologyMolecularFunction	MHC class I protein binding	HLA-B HLA-C MFSD6	4.54e-04	32	94	3	GO:0042288
GeneOntologyMolecularFunction	TAP complex binding	HLA-B HLA-C	7.73e-04	9	94	2	GO:0062061
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-B HLA-C	7.73e-04	9	94	2	GO:0042610
GeneOntologyMolecularFunction	TAP1 binding	HLA-B HLA-C	9.63e-04	10	94	2	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-B HLA-C	9.63e-04	10	94	2	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-B HLA-C	9.63e-04	10	94	2	GO:0046977
GeneOntologyMolecularFunction	transcription coregulator activity	CASP8AP2 BCLAF1 CAMTA2 CBX4 MED1 RUNX1T1 ARID5A NCOR2 SETD5	1.32e-03	562	94	9	GO:0003712
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-B HLA-C	1.40e-03	12	94	2	GO:0030881
GeneOntologyMolecularFunction	molecular adaptor activity	CASP8AP2 ANK2 BCLAF1 CAMTA2 CBX4 MED1 RUNX1T1 SPATA2 ARID5A NCOR2 SETD5 KIR2DL1 KIR2DS4 KIR3DL1 RHNO1	1.61e-03	1356	94	15	GO:0060090
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	5.08e-07	4	95	3	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	5.08e-07	4	95	3	IPR032754
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	5.08e-07	4	95	3	IPR029423
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	5.08e-07	4	95	3	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	5.08e-07	4	95	3	IPR015753
Domain	ig	KIR2DS2 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.24e-05	190	95	7	PF00047
Domain	Immunoglobulin	KIR2DS2 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.24e-05	190	95	7	IPR013151
Domain	PDZ	MAGI1 ARHGEF11 RGS12 MAST4 LNX1 PDZD2	8.33e-05	141	95	6	PF00595
Domain	PDZ	MAGI1 ARHGEF11 RGS12 MAST4 LNX1 PDZD2	1.09e-04	148	95	6	SM00228
Domain	-	MAGI1 ARHGEF11 RGS12 MAST4 LNX1 PDZD2	1.17e-04	150	95	6	2.30.42.10
Domain	PDZ	MAGI1 ARHGEF11 RGS12 MAST4 LNX1 PDZD2	1.22e-04	151	95	6	PS50106
Domain	PDZ	MAGI1 ARHGEF11 RGS12 MAST4 LNX1 PDZD2	1.26e-04	152	95	6	IPR001478
Domain	IG_LIKE	HLA-B HLA-C KIR2DS2 IGSF11 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.97e-04	491	95	10	PS50835
Domain	Ig-like_dom	HLA-B HLA-C KIR2DS2 IGSF11 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.39e-04	503	95	10	IPR007110
Domain	MHC_I_a_C	HLA-B HLA-C	3.79e-04	6	95	2	IPR010579
Domain	MHC_I_C	HLA-B HLA-C	3.79e-04	6	95	2	PF06623
Domain	RGS	ARHGEF11 RGS7 RGS12	7.42e-04	35	95	3	SM00315
Domain	RGS	ARHGEF11 RGS7 RGS12	8.06e-04	36	95	3	PS50132
Domain	Ig-like_fold	HLA-B HLA-C KIR2DS2 CAMTA2 IGSF11 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	9.08e-04	706	95	11	IPR013783
Domain	RGS	ARHGEF11 RGS7 RGS12	1.02e-03	39	95	3	IPR016137
Domain	IG	KIR2DS2 IGSF11 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.37e-03	421	95	8	SM00409
Domain	Ig_sub	KIR2DS2 IGSF11 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.37e-03	421	95	8	IPR003599
Domain	-	HLA-B HLA-C KIR2DS2 IGSF11 PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.99e-03	663	95	10	2.60.40.10
Domain	Chromodomain_CS	CHD2 CBX4	3.71e-03	18	95	2	IPR023779
Domain	SH3	TNK1 CACNB2 SH3D21 ARHGEF7 TNK2	4.93e-03	216	95	5	SM00326
Domain	SH3	TNK1 CACNB2 SH3D21 ARHGEF7 TNK2	4.93e-03	216	95	5	PS50002
Domain	MHC_I	HLA-B HLA-C	5.05e-03	21	95	2	PF00129
Domain	MHC_I_a_a1/a2	HLA-B HLA-C	5.05e-03	21	95	2	IPR001039
Domain	SH3_domain	TNK1 CACNB2 SH3D21 ARHGEF7 TNK2	5.32e-03	220	95	5	IPR001452
Domain	-	RGS7 RGS12	5.53e-03	22	95	2	1.10.196.10
Domain	RGS_subdom1	RGS7 RGS12	5.53e-03	22	95	2	IPR024066
Domain	PH_dom-like	ARHGEF11 CIT RGS12 ARHGEF7 OSBPL8 PLCB1 TNS4	6.04e-03	426	95	7	IPR011993
Domain	Chromo_domain	CHD2 CBX4	6.57e-03	24	95	2	IPR023780
Domain	-	HLA-B HLA-C	6.57e-03	24	95	2	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-B HLA-C	6.57e-03	24	95	2	IPR011161
Domain	Guanylate_kin	MAGI1 CACNB2	7.68e-03	26	95	2	PF00625
Domain	GK/Ca_channel_bsu	MAGI1 CACNB2	7.68e-03	26	95	2	IPR008145
Domain	Guanylate_kin-like_dom	MAGI1 CACNB2	7.68e-03	26	95	2	IPR008144
Domain	Chromo	CHD2 CBX4	7.68e-03	26	95	2	PF00385
Domain	GuKc	MAGI1 CACNB2	7.68e-03	26	95	2	SM00072
Domain	CHROMO_1	CHD2 CBX4	8.88e-03	28	95	2	PS00598
Domain	CHROMO_2	CHD2 CBX4	8.88e-03	28	95	2	PS50013
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	HLA-B HLA-C KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.29e-07	88	69	7	M16004
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-B HLA-C KIR2DL1 KIR2DL2 KIR3DL1	1.59e-06	41	69	5	M13519
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	HLA-B HLA-C KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.59e-06	137	69	7	M5669
Pathway	REACTOME_DAP12_INTERACTIONS	HLA-B HLA-C KIR2DL1 KIR2DS4 KIR3DL1	6.37e-06	54	69	5	MM14871
Pathway	REACTOME_DAP12_INTERACTIONS	HLA-B HLA-C KIR2DS2 KIR2DS4	7.35e-05	46	69	4	M27151
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-B HLA-C	3.50e-04	6	69	2	M47468
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-B HLA-C	4.88e-04	7	69	2	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-B HLA-C	4.88e-04	7	69	2	M47530
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	HLA-B HLA-C KIR2DL1 KIR2DS4 KIR3DL1	5.14e-04	135	69	5	MM14781
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.20e-18	12	103	8	19181658
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.70e-18	13	103	8	19934297
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.84e-17	15	103	8	19850842
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.84e-17	15	103	8	19493232
Pubmed	No association of KIR genes with Behcet's disease.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.66e-17	16	103	8	17868255
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.07e-16	17	103	8	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.07e-16	17	103	8	20483367
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.07e-16	17	103	8	19968064
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.07e-16	17	103	8	19169284
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.91e-16	18	103	8	19630074
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.91e-16	18	103	8	20519398
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.91e-16	18	103	8	20200544
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.91e-16	18	103	8	19846535
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.91e-16	18	103	8	20580654
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.91e-16	18	103	8	20210918
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	3.30e-16	19	103	8	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	3.30e-16	19	103	8	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	3.30e-16	19	103	8	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	3.30e-16	19	103	8	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.48e-16	20	103	8	20193031
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.48e-16	20	103	8	20426625
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	8.84e-16	21	103	8	19861144
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.27e-15	12	103	7	19936734
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.39e-15	22	103	8	20492596
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.75e-15	13	103	7	19120281
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.02e-14	15	103	7	20356536
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.02e-14	15	103	7	20643584
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.02e-14	15	103	7	19326408
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.82e-14	16	103	7	20652381
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.82e-14	16	103	7	18643961
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	HLA-B KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.82e-14	16	103	7	20331834
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.82e-14	16	103	7	20210919
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.83e-14	29	103	8	20082482
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	HLA-B HLA-C KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	3.08e-14	17	103	7	19032228
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4	3.08e-14	17	103	7	20173784
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.85e-14	9	103	6	7749980
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	HLA-C KIR2DS2 KIR2DL1 KIR2DS3 KIR2DS4 KIR3DL1	4.85e-14	9	103	6	18340360
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.03e-14	18	103	7	19046302
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	HLA-B HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	9.88e-14	35	103	8	19683555
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.66e-13	11	103	6	18830515
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.66e-13	11	103	6	19664392
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.30e-13	12	103	6	20371502
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	HLA-C KIR2DS2 KIR2DL1 KIR2DS3 KIR2DS4 KIR3DL1	5.30e-13	12	103	6	20137308
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	9.82e-13	13	103	6	18687225
Pubmed	KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.	HLA-B HLA-C KIR2DS2 KIR2DL2 KIR3DL1	1.24e-12	6	103	5	24349500
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.71e-12	14	103	6	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.71e-12	14	103	6	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.71e-12	14	103	6	15896204
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.71e-12	14	103	6	19489269
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.85e-12	15	103	6	20082646
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.85e-12	15	103	6	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.85e-12	15	103	6	20207982
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.85e-12	15	103	6	17498266
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR3DL1	4.32e-12	7	103	5	14607943
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	20670355
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	19527230
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	18668235
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	19279038
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	4.55e-12	16	103	6	16403292
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	7.02e-12	17	103	6	19218127
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	7.02e-12	17	103	6	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	7.02e-12	17	103	6	20650299
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	7.02e-12	17	103	6	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	7.02e-12	17	103	6	19761533
Pubmed	Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.	HLA-B HLA-C KIR2DL1 KIR2DL2 KIR3DL1	1.15e-11	8	103	5	20935224
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4	1.15e-11	8	103	5	18681957
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.58e-11	9	103	5	8662091
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1	5.14e-11	10	103	5	12559621
Pubmed	KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.	HLA-B HLA-C KIR2DL1 KIR3DL1	7.25e-11	4	103	4	28686681
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.	HLA-B KIR2DL1 KIR2DS3 KIR3DL1	3.62e-10	5	103	4	16508981
Pubmed	Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.	HLA-B HLA-C KIR2DS2 KIR2DS3	3.62e-10	5	103	4	26472014
Pubmed	Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.	HLA-B HLA-C KIR2DL1 KIR2DL2	3.62e-10	5	103	4	18322206
Pubmed	Killer cell immunoglobulin-like receptor genotypes in Japanese patients with type 1 diabetes.	HLA-B HLA-C KIR2DL1 KIR3DL1	3.62e-10	5	103	4	17990989
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4 KIR3DL1	4.05e-10	14	103	5	18945962
Pubmed	KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C.	HLA-B HLA-C KIR2DL1 KIR2DS4	1.08e-09	6	103	4	19858347
Pubmed	A human MAP kinase interactome.	MAGI1 CASP8AP2 HIVEP1 HLA-B NUP214 ARHGEF11 MEF2D CEP350 ARHGEF7 PLCB1 COBL TNK2 CGNL1	2.26e-09	486	103	13	20936779
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS4	2.52e-09	7	103	4	11169255
Pubmed	HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.	HLA-B HLA-C KIR2DS4 KIR3DL1	5.03e-09	8	103	4	27649529
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DL2 KIR2DS4 KIR3DL1	5.03e-09	8	103	4	17200871
Pubmed	A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.	KIR2DL1 KIR2DL2 KIR2DS4 KIR3DL1	5.03e-09	8	103	4	15730517
Pubmed	Distribution of KIR genes in the Czech population.	HLA-C KIR2DL1 KIR2DS4 KIR3DL1	9.04e-09	9	103	4	18186800
Pubmed	Distinctive KIR and HLA diversity in a panel of north Indian Hindus.	HLA-B HLA-C KIR2DL1 KIR3DL1	1.50e-08	10	103	4	11904677
Pubmed	HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.	HLA-B HLA-C KIR2DL2 KIR2DS4	1.50e-08	10	103	4	24018270
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.50e-08	10	103	4	21206914
Pubmed	Evaluation of the genetic diversity of KIR genes in patients with endometrial cancer.	KIR2DS2 KIR2DL2 KIR2DS4	2.52e-08	3	103	3	38387251
Pubmed	Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.	HLA-C KIR2DS2 KIR2DL2	2.52e-08	3	103	3	20082621
Pubmed	Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.	HLA-B HLA-C KIR3DL1	2.52e-08	3	103	3	20574122
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1	3.53e-08	12	103	4	17490516
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAGI1 TNK1 HIVEP1 TEX2 CBX4 MEF2D RGS12 CEP350 KIAA1671 MAST4 OSBPL8 COBL CGNL1 CAMSAP2 USP6NL	3.85e-08	861	103	15	36931259
Pubmed	B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.	HLA-C KIR2DL1 KIR2DL2	1.01e-07	4	103	3	20056126
Pubmed	HLA-C and KIR genes in hepatitis C virus infection.	HLA-C KIR2DL1 KIR2DL2	1.01e-07	4	103	3	16571411
Pubmed	Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.	HLA-C KIR2DS2 KIR2DL2	1.01e-07	4	103	3	16929347
Pubmed	Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.	KIR2DL1 KIR2DS4 KIR3DL1	1.01e-07	4	103	3	18632158
Pubmed	KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.	HLA-B HLA-C KIR3DL1	1.01e-07	4	103	3	21797986
Pubmed	KIR/HLA ligand incompatibility in kidney transplantation.	HLA-C KIR2DS2 KIR2DL2	1.01e-07	4	103	3	18091530
Pubmed	[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].	HLA-C KIR2DL1 KIR2DL2	1.01e-07	4	103	3	18543232
Pubmed	Peptide-specific engagement of the activating NK cell receptor KIR2DS1.	HLA-B HLA-C KIR2DL1	1.01e-07	4	103	3	28546555
Interaction	KIR2DL2 interactions	HLA-C KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1	1.89e-11	13	98	6	int:KIR2DL2
Interaction	KIR3DL1 interactions	HLA-B KIR2DS2 KIR2DL1 KIR2DL2 KIR3DL1	3.06e-09	13	98	5	int:KIR3DL1
Interaction	KIR2DL1 interactions	HLA-C PTPRD KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1	3.91e-09	28	98	6	int:KIR2DL1
Interaction	YWHAH interactions	MAGI1 TNK1 HIVEP1 TEX2 CBX4 MED1 ATXN1L MEF2D RGS12 PYHIN1 CEP350 KIAA1671 MAST4 ARHGEF7 OSBPL8 PACS2 COBL CGNL1 CAMSAP2 CLEC16A USP6NL	5.83e-08	1102	98	21	int:YWHAH
Interaction	KIR2DS2 interactions	HLA-C KIR2DS2 KIR2DL2 KIR2DS3 KIR3DL1	9.45e-07	37	98	5	int:KIR2DS2
Interaction	HLA-C interactions	DNAJB12 GPR50 HLA-B HLA-C TEX2 KIR2DS2 CIT KIR2DL1 KIR2DL2 KIR2DS4 CLEC16A	1.17e-06	353	98	11	int:HLA-C
Interaction	SFN interactions	MAGI1 TNK1 TEX2 CBX4 RGS12 CEP350 KIAA1671 MAST4 PACS2 COBL TNS4 CGNL1 CAMSAP2 USP6NL RPL18	1.21e-06	692	98	15	int:SFN
Interaction	SYNE3 interactions	DNAJB12 HLA-C TEX2 NUP214 SPATA2 CLCC1 JPH1 CEP350 KIAA1671 NCOR2 OSBPL8 CGNL1	1.65e-06	444	98	12	int:SYNE3
Interaction	YWHAG interactions	MAGI1 TNK1 HIVEP1 BCLAF1 CBX4 MEF2D RGS12 PYHIN1 CEP350 KIAA1671 MAST4 ARHGEF7 OSBPL8 PACS2 COBL TNK2 CGNL1 LNX1 CAMSAP2 USP6NL	1.96e-06	1248	98	20	int:YWHAG
Interaction	KIR2DS3 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3	2.40e-06	20	98	4	int:KIR2DS3
Interaction	GSK3A interactions	TEX2 BCLAF1 LRRC37A2 ARHGEF11 CEP350 KIAA1671 MAST4 COBL CAMSAP2 SLX4 RPL18	1.58e-05	464	98	11	int:GSK3A
Interaction	KIR2DS4 interactions	HLA-C KIR2DS4	2.34e-05	2	98	2	int:KIR2DS4
Interaction	HNF1B interactions	HIVEP1 BCLAF1 ATXN1L MEF2D NCOR2 CABIN1 RPL18	3.98e-05	190	98	7	int:HNF1B
Interaction	CBFA2T2 interactions	RUNX1T1 ATXN1L NCOR2 TAL1	6.72e-05	45	98	4	int:CBFA2T2
Interaction	SDC2 interactions	GPR50 TEX2 CBX4 PYHIN1 GTF3C1 OSBPL8	7.08e-05	143	98	6	int:SDC2
Interaction	YWHAB interactions	MAGI1 TNK1 HIVEP1 CBX4 RGS7 RGS12 CEP350 KIAA1671 MAST4 ARHGEF7 PACS2 CGNL1 LNX1 CAMSAP2 USP6NL	1.10e-04	1014	98	15	int:YWHAB
Interaction	MIEN1 interactions	HIVEP1 ARID5A NLGN3	1.20e-04	20	98	3	int:MIEN1
Interaction	NLGN3 interactions	HIVEP1 NLGN3 PTPRD COBL TNK2	1.22e-04	99	98	5	int:NLGN3
Interaction	RHOC interactions	HLA-B HLA-C MFSD6 ABCC5 ARHGEF11 CIT CLCC1 JPH1 OSBPL8 LNX1 CLEC16A	1.26e-04	584	98	11	int:RHOC
Interaction	KIR3DP1 interactions	KIR2DS2 KIR2DL1	1.40e-04	4	98	2	int:KIR3DP1
Interaction	KIR2DS1 interactions	HLA-C KIR2DS2	1.40e-04	4	98	2	int:KIR2DS1
Interaction	DNAJC16 interactions	HLA-B HLA-C CLCC1 JPH1 OSBPL8 CLEC16A RPL18	1.43e-04	233	98	7	int:DNAJC16
Interaction	EYA4 interactions	CBX4 SPATA2 ATXN1L NCOR2 AMOTL1 AUTS2 SPTY2D1	1.85e-04	243	98	7	int:EYA4
Interaction	YWHAZ interactions	TNK1 HIVEP1 TEX2 CBX4 SPATA2 RGS12 KIAA1671 MAST4 ARHGEF7 AMOTL1 OSBPL8 PACS2 TNK2 CGNL1 LNX1 CAMSAP2 USP6NL	1.95e-04	1319	98	17	int:YWHAZ
Interaction	PAX8 interactions	HIVEP1 ATXN1L CIT MEF2D NCOR2	2.09e-04	111	98	5	int:PAX8
Interaction	ASF1A interactions	CASP8AP2 HIVEP1 MEF2D NCOR2 GTF3C1 CABIN1 SPTY2D1	2.15e-04	249	98	7	int:ASF1A
Interaction	NUP43 interactions	CASP8AP2 HIVEP1 BCLAF1 CCDC168 NUP214 CIT KANSL3 NCOR2 SLX4 RPL18 PDZD2	2.27e-04	625	98	11	int:NUP43
Interaction	PRRT3 interactions	PTPRD PRRT3	2.32e-04	5	98	2	int:PRRT3
Cytoband	19q13.4	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	2.68e-08	79	103	6	19q13.4
Cytoband	3p25.3	FANCD2OS SETD5 PRRT3	1.45e-04	45	103	3	3p25.3
Cytoband	6q22-q23	BCLAF1 LAMA2	2.22e-04	10	103	2	6q22-q23
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	9.62e-12	18	54	6	620
GeneFamily	PDZ domain containing	MAGI1 ARHGEF11 RGS12 MAST4 LNX1 PDZD2	5.92e-06	152	54	6	1220
GeneFamily	Regulators of G-protein signaling	RGS7 RGS12	1.77e-03	21	54	2	720
GeneFamily	Ataxins\|Trinucleotide repeat containing	MAGI1 NCOR2	2.51e-03	25	54	2	775
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	MAGI1 CACNB2	2.72e-03	26	54	2	904
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR3DL1	1.35e-06	49	102	5	M40909
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL	BORCS6 HLA-B MFSD6 FXYD5 CBX4 ARHGEF11 CBS ARID5A KIAA1671 CARD6 COBL LNX1 IQCE	9.92e-06	775	102	13	M45713
Coexpression	GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN	DNAJB12 CBX4 MEF2D GVINP1 ARHGEF7 CAMSAP2 USP6NL	1.27e-05	198	102	7	M7708
Coexpression	GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP	RUNX1T1 ATXN1L CIT AMOTL1 AUTS2 ZFYVE26 IQCE	1.36e-05	200	102	7	M8469
Coexpression	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	CACNB2 BCLAF1 PTPRD TAL1 PDZD2	1.64e-05	81	102	5	M17082
Coexpression	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	RUNX1T1 PTPRD AUTS2 CLEC16A	8.35e-05	59	102	4	M1238
Coexpression	DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	RUNX1T1 PTPRD AUTS2 CLEC16A	8.35e-05	59	102	4	MM528
Coexpression	MASSARWEH_TAMOXIFEN_RESISTANCE_UP	MFSD6 ABCC5 RAB20 ATXN1L PRRT3 LNX1 MUC2 SPTY2D1 IQCE PDZD2	9.34e-05	583	102	10	M17454
Coexpression	ZIRN_TRETINOIN_RESPONSE_WT1_UP	ZNF133 KANSL3 TAL1	9.57e-05	23	102	3	M17312
Coexpression	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	GLIPR1 NUP214 RAB20 KIR3DL1	1.08e-04	63	102	4	M9775
Coexpression	TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING	HLA-B HLA-C FXYD5	1.09e-04	24	102	3	MM3773
Coexpression	GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	HIVEP1 FXYD5 CHD2 NUP214 SPATA2 USP6NL	1.20e-04	196	102	6	M4244
Coexpression	GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN	MAGI1 CASP8AP2 ABCC5 CIT CEP350 RPL18	1.24e-04	197	102	6	M7683
Coexpression	GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN	NCOR2 OSBPL8 PLCB1 TNK2 CABIN1 CAMSAP2	1.31e-04	199	102	6	M8388
Coexpression	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN	HLA-B HLA-C RGS12 GVINP1 OSBPL8 CAMSAP2	1.31e-04	199	102	6	M3440
Coexpression	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN	HLA-C KIR2DS2 GTF3C1 AUTS2 KIR2DL1 KIR2DL2	1.31e-04	199	102	6	M9885
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 CACNB2 ANK2 RGS7 MAST4 PLCB1 CGNL1 LNX1	9.40e-09	183	101	8	31ab55d5f3639f5964541d5eae23044dbda3356e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 CACNB2 ANK2 RGS7 MAST4 PLCB1 CGNL1 LNX1	1.02e-08	185	101	8	898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MAGI1 CACNB2 ANK2 RGS7 MAST4 PLCB1 CGNL1 LNX1	1.11e-08	187	101	8	b93cf4dfe8ffb89348ee7bccc9f284189f7240a2
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.04e-07	194	101	7	c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 CHD2 CIT MAST4 PTPRD AUTS2 PDZD2	3.04e-07	194	101	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.04e-07	194	101	7	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	10x5'-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.14e-07	195	101	7	c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.14e-07	195	101	7	e756733cf48768bf40058d6cf9039e52f7563133
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.25e-07	196	101	7	a3b077e82b1550eb328c84b567b60179001f9a77
ToppCell	10x5'-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.25e-07	196	101	7	1868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCell	severe_COVID-19-NK\|World / disease group, cell group and cell class (v2)	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.49e-07	198	101	7	36b1370ef68c4bbe0268933a6ef5e6022d992bdf
ToppCell	mild_COVID-19-NK\|mild_COVID-19 / disease group, cell group and cell class (v2)	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	3.61e-07	199	101	7	4854f25ee436e1cf577744373ffd87b1221d2b88
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A3 LAMA2 CCDC168 RUNX1T1 ARID5A NLGN3	2.19e-06	166	101	6	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A3 LAMA2 CCDC168 RUNX1T1 ARID5A NLGN3	2.19e-06	166	101	6	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	droplet-Marrow-BM-1m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNK1 PYHIN1 NLGN3 GVINP1 AUTS2 PACS2	2.34e-06	168	101	6	2e88d9cb7c80a4656fab290db8b45a5a0599d769
ToppCell	droplet-Marrow-nan-3m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLCC1 PYHIN1 KANSL3 GTF3C1 GVINP1 ARHGEF7	2.42e-06	169	101	6	5f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCell	NS-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PYHIN1 PLCB1 AUTS2 KIR2DL1 KIR2DL2 KIR3DL1	2.59e-06	171	101	6	adda76991d9b150bb8ccf3989b7cbbf41843cf0b
ToppCell	ASK428-Immune-NK_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	HLA-B HLA-C PYHIN1 KIR2DL1 KIR2DL2 KIR3DL1	3.49e-06	180	101	6	857d09446e3e6737e83d0f10bfda2ba282d5ba75
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 ABCC5 MAST4 PLCB1 CGNL1 LNX1	3.49e-06	180	101	6	9e09b3dfe344b5d50520711513d389865d73a861
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 RGS7 MAST4 PLCB1 CGNL1 LNX1	3.49e-06	180	101	6	eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCell	ASK440-Immune-NK_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	HLA-B HLA-C PYHIN1 KIR2DL1 KIR2DL2 KIR3DL1	3.49e-06	180	101	6	340e750356d23fe9af0e8f298f8a273ff426052f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 RGS7 MAST4 PLCB1 CGNL1 LNX1	3.49e-06	180	101	6	a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	MAGI1 CACNB2 ANK2 LAMA2 MAST4 PDZD2	3.96e-06	184	101	6	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-B HLA-C PYHIN1 KIR2DL1 KIR2DS4 KIR3DL1	4.21e-06	186	101	6	1590fe72badffc79f1d390deb3207116ac2281bb
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-B HLA-C PYHIN1 KIR2DL1 KIR2DS4 KIR3DL1	4.21e-06	186	101	6	e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	MAGI1 ANK2 RGS7 CGNL1 LNX1 PDZD2	4.48e-06	188	101	6	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 CACNB2 ANK2 LAMA2 MAST4 PDZD2	4.62e-06	189	101	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	(1)_T_CD8_gd\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	HLA-B HLA-C PYHIN1 KIAA1671 KIR2DL1 KIR3DL1	4.62e-06	189	101	6	62eda4bcfd21d5025ac676d524994ede22721c1d
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	MAGI1 CACNB2 ANK2 LAMA2 JPH1 MAST4	4.76e-06	190	101	6	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	MAGI1 CACNB2 ANK2 LAMA2 MAST4 PDZD2	4.76e-06	190	101	6	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	Control-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	PYHIN1 GTF3C1 PLCB1 AUTS2 KIR2DS4 KIR3DL1	4.76e-06	190	101	6	1584c68b58c7f406d9b0e8451beea3e6f8980c56
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	MAGI1 CACNB2 ANK2 LAMA2 MAST4 PDZD2	4.76e-06	190	101	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 RGS7 MAST4 PLCB1 CGNL1 LNX1	4.76e-06	190	101	6	cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KIAA1671 MAST4 PTPRD COBL CGNL1 PDZD2	4.91e-06	191	101	6	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	MAGI1 CACNB2 ANK2 LAMA2 MAST4 PDZD2	4.91e-06	191	101	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KIAA1671 MAST4 PTPRD COBL CGNL1 PDZD2	4.91e-06	191	101	6	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAST4 PTPRD AUTS2 CGNL1 PDZD2	4.91e-06	191	101	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 AUTS2 KIR2DL1 KIR3DL1	4.91e-06	191	101	6	f802a4686ecf00e8302047bfe23356f24b266cf8
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI1 JPH1 MAST4 COBL MYRF PDZD2	4.91e-06	191	101	6	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 MAST4 AUTS2 COBL CGNL1 PDZD2	4.91e-06	191	101	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 AUTS2 KIR2DL1 KIR3DL1	5.06e-06	192	101	6	4d72b9264ed62e0c08cde4078061b348253f6989
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MAGI1 MAST4 AUTS2 COBL CGNL1 PDZD2	5.06e-06	192	101	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	HLA-B PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	5.21e-06	193	101	6	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	ICU-SEP-Lymphocyte-T_NK-NK\|ICU-SEP / Disease, Lineage and Cell Type	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.21e-06	193	101	6	f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	HLA-B HLA-C RUNX1T1 KIAA1671 PLCB1 LNX1	5.21e-06	193	101	6	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GLIPR1 HLA-B HLA-C PYHIN1 KIR2DL1 KIR3DL1	5.36e-06	194	101	6	3fe32e38c95135d152acb1624fec1623339e144a
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.36e-06	194	101	6	fa72c2f3e6b8bfc2ef126deb219ec6a44809385b
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR3DL1	5.36e-06	194	101	6	ecdfc27d06e363fb23f0309f26ef6404a89f14ec
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.36e-06	194	101	6	bc7c4efe2a82057fb95582da983e36f413990902
ToppCell	lymphoid-NK_cell\|World / Lineage, cell class and subclass	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.36e-06	194	101	6	4bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.36e-06	194	101	6	b43788e458a80ab93f485f4577370aec448ad95e
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-B PYHIN1 GTF3C1 KIR2DL1 KIR2DS4 KIR3DL1	5.36e-06	194	101	6	ae5357e2a276473cde1fc8c43acaf9f69da35fd7
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-innate_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-B PYHIN1 GTF3C1 KIR2DL1 KIR2DS4 KIR3DL1	5.36e-06	194	101	6	3a0b8b5d0354c43da57bb951cd8ba878363c3de5
ToppCell	IIF-Lymphocyte-T_NK-NK\|IIF / Disease, Lineage and Cell Type	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.52e-06	195	101	6	464ce05cb52f78aee22d3baa6641b37bd53aae16
ToppCell	3'_v3-blood-Lymphocytic_NK-NK_CD16\|blood / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1	5.52e-06	195	101	6	789149fb52d9d16393e1649358515add60d37f2d
ToppCell	wk_20-22-Hematologic_Lymphocytic-NK\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	HLA-B HLA-C ARID5A PYHIN1 KIR2DL1 KIR3DL1	5.52e-06	195	101	6	a868aadca4a81cfeb773a18b0daad1ea5ece8fa8
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MAGI1 CACNB2 ANK2 LAMA2 MAST4 COBL	5.52e-06	195	101	6	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	3'_v3-blood-Lymphocytic_NK\|blood / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1	5.52e-06	195	101	6	731a454e45c7b610e0140312bcabaea711dcc766
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	HLA-B HLA-C RUNX1T1 KIAA1671 PLCB1 LNX1	5.52e-06	195	101	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	T/NK_cells-CD56dim_NK_cell\|World / Lineage and Cell class	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.52e-06	195	101	6	6124e87cb9061bf8918377fb4a79084079ddfc16
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	HLA-B LAMA2 PYHIN1 GFY GTF3C1 KIR2DL2	5.52e-06	195	101	6	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	(0)_NK_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.69e-06	196	101	6	9b080859130cf156bfa833dc71fd39734cb9a32d
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-B LAMA2 PYHIN1 GFY GTF3C1 KIR2DL2	5.69e-06	196	101	6	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-B LAMA2 PYHIN1 GFY GTF3C1 KIR2DL2	5.69e-06	196	101	6	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	(0)_NK\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.69e-06	196	101	6	e2578a562d9903a33a7c60db229005680af8141c
ToppCell	10x5'-Liver-Lymphocytic_NK-NK_CD16\|Liver / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.69e-06	196	101	6	e6d4853ccefbcd45a019cee595811f0474dcc036
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-B LAMA2 PYHIN1 GFY GTF3C1 KIR2DL2	5.69e-06	196	101	6	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	HLA-C PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	5.69e-06	196	101	6	f7e5a7fad4547e8ab9ab8b140239281832fb4260
ToppCell	tumor_Lung-T/NK_cells-NK\|tumor_Lung / Location, Cell class and cell subclass	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	5.69e-06	196	101	6	006e630f3d8033f45c6b7e9154d77000c7b0cb70
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-B LAMA2 PYHIN1 GFY GTF3C1 KIR2DL2	5.69e-06	196	101	6	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8\|blood / Manually curated celltypes from each tissue	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR3DL1	5.86e-06	197	101	6	13e6611cde9364f0c1bf681b0b26c4d2725e5f4a
ToppCell	mild-Lymphocytic-NK_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HLA-B HLA-C PYHIN1 KIR2DL1 KIR2DS4 KIR3DL1	6.03e-06	198	101	6	1d20fc9948965de52a98f758035edfdd12cafc5f
ToppCell	(0)_NK_FCGR3Apos\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.03e-06	198	101	6	13f10f9233fc1523f0da2d9d59f3ced9c51a603a
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B\|390C / Donor, Lineage, Cell class and subclass (all cells)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.03e-06	198	101	6	0dc4a564dcab8ac42f238f98ee1f2090b0dcffe6
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-NK\|Multiple_Sclerosis / Disease, Lineage and Cell Type	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.03e-06	198	101	6	d413020012977eb8da0a5641dd16d0b0a60bec38
ToppCell	390C-Lymphocytic-NK_cells\|390C / Donor, Lineage, Cell class and subclass (all cells)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.03e-06	198	101	6	872ddb2738c5e0375830bb0e5b2c50383bf58738
ToppCell	(2)_NK/T-(22)_CD8+_T_cell-(220)_CD8+_Cytotoxic_T_cell\|(22)_CD8+_T_cell / immune cells in Peripheral Blood (logTPM normalization)	GLIPR1 HLA-B HLA-C PYHIN1 GTF3C1 PLCB1	6.03e-06	198	101	6	1bb60688ff0e42471c8b646652fe95b9b28c41a3
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-NK\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.03e-06	198	101	6	e39ef71f3a9e0591bc0300ae132036fe2f8d5716
ToppCell	COVID_vent-Lymphocytic-ILC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HLA-B PYHIN1 AUTS2 KIR2DL1 KIR2DL2 KIR3DL1	6.21e-06	199	101	6	e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-B PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	b03539908131308d7bf5036e78c4c840a6a79a17
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A\|390C / Donor, Lineage, Cell class and subclass (all cells)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	f72db89fe7e511473fc849f8fadb8b6453ac8ae5
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	eb05ccae5187e4701bbbe6d714a6d2808fbcf306
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	10c8729b779073c3bf808e85958d59147f0be5c5
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	867fd292f3879982422e840e087bfdb3b21a8715
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-B PYHIN1 GTF3C1 AUTS2 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	7d071c88a003babf6dbdb84dde561fc03c92f375
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	5e9fe852a70546c9d235414a2c26ca3e67ba6eb9
ToppCell	Control-Lymphoid_T/NK-NK\|Control / Disease group, lineage and cell class	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	94b2693a8378b9b2c58c6aebb2c6658d75b2e3de
ToppCell	COVID_vent-Lymphocytic-ILC-NK_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	HLA-B PYHIN1 AUTS2 KIR2DL1 KIR2DL2 KIR3DL1	6.21e-06	199	101	6	5f914962e2572b0c6372465b81b7496fa663d93c
ToppCell	severe-gd_T\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-B HLA-C PYHIN1 GTF3C1 PLCB1 AUTS2	6.21e-06	199	101	6	e5a17a9f8f3be05d6abe1116607d17633df3c7ef
ToppCell	PBMC-Control-Lymphocyte-T/NK-NK_cell-NK\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.21e-06	199	101	6	d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-B HLA-C FXYD5 ARID5A PYHIN1 RPL18	6.39e-06	200	101	6	cf4d184ff07862fabb182dabf09b2c9aac491409
ToppCell	MS-IIF-Lymphocyte-T/NK-NK\|IIF / Disease, condition lineage and cell class	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.39e-06	200	101	6	4f889cc5ab76a128fd781d927b0d8368f4f927b7
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-NK\|ICU-SEP / Disease, condition lineage and cell class	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.39e-06	200	101	6	6813fa6d24950fac22e2b5bb26b64f79214163b6
ToppCell	severe-NK\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HLA-B HLA-C PYHIN1 GTF3C1 AUTS2 KIR3DL1	6.39e-06	200	101	6	64e8a6c36e0c654b7b2416c9f19b9058215222b1
ToppCell	Control-Control-Lymphocyte-T/NK-NK\|Control / Disease, condition lineage and cell class	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.39e-06	200	101	6	c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-NK\|Multiple_Sclerosis / Disease, condition lineage and cell class	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1 KIR3DL1	6.39e-06	200	101	6	d7a611d88107d84b5995b353e8cf95c6a7eb79de
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-B HLA-C PYHIN1 PLCB1 KIR2DL1 KIR3DL1	6.39e-06	200	101	6	0f8e2fed93cc103b20a825d8d3e83787c5c015cc
ToppCell	BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)\|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-B HLA-C PYHIN1 GTF3C1 KIR2DL1	2.00e-05	145	101	5	6dd81d53d006fcc206a10969374a11c372f92133
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_A\|368C / Donor, Lineage, Cell class and subclass (all cells)	PYHIN1 KIAA1671 KIR2DL1 KIR3DL1 TAL1	2.07e-05	146	101	5	0e38e1fa40b1fcd1bb61f7af7cc2206846c192ae
Computational	Neighborhood of IL2RB	KIR2DS2 KIR2DL1 KIR2DS4 KIR3DL1	1.37e-04	46	62	4	GNF2_IL2RB
Drug	D-Au	HLA-B HLA-C KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	5.11e-08	77	101	7	CID000277822
Drug	Aa1	GLIPR1 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS4 KIR3DL1	1.88e-06	83	101	6	CID009549188
Drug	Imidurea [39236-46-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A	GLIPR1 CACNB2 FXYD5 NUP214 ARID5A NCOR2 PLCB1 AUTS2	2.57e-06	195	101	8	3522_UP
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	BORCS6 DNAJB12 ANK2 NUP214 RGS12 NCOR2 PTPRD TNK2	2.87e-06	198	101	8	6651_UP
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; MCF7; HT_HG-U133A	BORCS6 MFSD6 CBX4 SH3D21 ARID5A PLCB1 AUTS2 CABIN1	3.10e-06	200	101	8	4953_UP
Drug	vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A	GLIPR1 TNK1 CAMTA2 CLCC1 COBL TNK2 CABIN1	2.40e-05	192	101	7	7556_UP
Drug	Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A	BORCS6 CBX4 ARHGEF11 RGS12 PLCB1 IQCE RPL18	2.82e-05	197	101	7	3431_UP
Drug	Sulfabenzamide [127-71-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A	GLIPR1 CACNB2 LAMA2 NUP214 MEF2D MAST4 PLCB1	2.82e-05	197	101	7	4979_UP
Drug	Praziquantel [55268-74-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A	GLIPR1 ANK2 RUNX1T1 ARID5A RGS12 PLCB1 TNK2	2.82e-05	197	101	7	3189_UP
Drug	AC1L1FCN	HLA-B HLA-C KIR3DL1	3.71e-05	15	101	3	CID000003178
Disease	alcohol consumption measurement	MAGI1 HLA-B MFSD6 IGSF11 MED1 RUNX1T1 CIT RGS12 NCOR2 MAST4 PLCB1 AUTS2 COBL TAL1 CLEC16A IQCE	4.85e-06	1242	101	16	EFO_0007878
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	HLA-B HLA-C KIR2DL1	1.72e-05	15	101	3	EFO_0801746
Disease	amyloid-beta measurement	CACNB2 CHD2 NCOR2 PTPRD PLCB1 CGNL1 LNX1 PDZD2	3.10e-05	355	101	8	EFO_0005194
Disease	anxiety disorder, panic disorder	BORCS6 IQCE	3.47e-05	3	101	2	EFO_0004262, EFO_0006788
Disease	Schizophrenia	MAGI1 CACNB2 GPR50 HLA-B HLA-C LAMA2 ARHGEF11 CBS RGS12 PLCB1 AUTS2 CGNL1	4.97e-05	883	101	12	C0036341
Disease	event-related brain oscillation	ARID5A KANSL3	6.93e-05	4	101	2	EFO_0004358
Disease	allergic asthma (is_implicated_in)	HLA-B HLA-C	1.15e-04	5	101	2	DOID:9415 (is_implicated_in)
Disease	corpus callosum central volume measurement	LNX1 CLEC16A PDZD2	1.20e-04	28	101	3	EFO_0010296
Disease	cysteine-rich with EGF-like domain protein 1 measurement	FANCD2OS SETD5 PRRT3	1.80e-04	32	101	3	EFO_0021870
Disease	alopecia (is_implicated_in)	FOXN1 HLA-B	2.41e-04	7	101	2	DOID:987 (is_implicated_in)
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-B HLA-C	2.41e-04	7	101	2	DOID:0081267 (implicated_via_orthology)
Disease	LEUKEMIA, ACUTE LYMPHOBLASTIC	NUP214 TAL1	3.20e-04	8	101	2	613065
Disease	Acute lymphoid leukemia	NUP214 TAL1	3.20e-04	8	101	2	cv:C0023449
Disease	human immunodeficiency virus infectious disease (is_implicated_in)	HLA-B HLA-C KIR3DL1	3.25e-04	39	101	3	DOID:526 (is_implicated_in)
Disease	cryptic phenotype measurement	CACNB2 SLC27A6 PLCB1	5.66e-04	47	101	3	EFO_0021487
Disease	beta-2 microglobulin measurement	HLA-B HLA-C	6.25e-04	11	101	2	EFO_0005197
Disease	interstitial collagenase measurement	MMP20 MEF2D	6.25e-04	11	101	2	EFO_0008193
Disease	adult onset asthma	HLA-B MUC2 MYRF CLEC16A	7.36e-04	118	101	4	EFO_1002011
Disease	linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement	MYRF PDZD2	7.49e-04	12	101	2	EFO_0800500
Disease	severe acute respiratory syndrome, COVID-19	MAGI1 PMS2 PTPRD ARHGEF7 AUTS2 KIR2DS4 PDZD2	8.84e-04	447	101	7	EFO_0000694, MONDO_0100096
Disease	Nasal Cavity Polyp	HLA-B MYRF CLEC16A	8.97e-04	55	101	3	EFO_1000391
Disease	Alzheimer's disease (implicated_via_orthology)	HIVEP1 ANK2 PLCB1	9.96e-04	57	101	3	DOID:10652 (implicated_via_orthology)
Disease	childhood onset asthma	HLA-B LAMA2 MED1 PTPRD CLEC16A PDZD2	1.03e-03	334	101	6	MONDO_0005405
Disease	white matter integrity	HLA-B HLA-C IGSF11 LNX1	1.06e-03	130	101	4	EFO_0004641
Disease	asthma	MAGI1 HIVEP1 HLA-B MED1 PYHIN1 LNX1 MUC2 MYRF CLEC16A	1.11e-03	751	101	9	MONDO_0004979
Disease	severe aplastic anemia	HLA-B SLC27A6	1.18e-03	15	101	2	EFO_0006927
Disease	diffuse plaque measurement	CACNB2 ANK2 SLC27A6 NCOR2 MAST4 PTPRD PLCB1 LINC00114 LNX1	1.18e-03	758	101	9	EFO_0010699
Disease	body weight	ZNF133 CACNB2 HIVEP1 HLA-B RUNX1T1 SPATA31C1 MAST4 ARHGEF7 AUTS2 LNX1 TAL1 PDZD2	1.26e-03	1261	101	12	EFO_0004338
Disease	urate measurement, bone density	GLIPR1 CASP8AP2 ZNF133 MAST4 PTPRD PLCB1 CABIN1 PDZD2	1.31e-03	619	101	8	EFO_0003923, EFO_0004531
Disease	–	HLA-C KIR3DL1	1.35e-03	16	101	2	609423
Disease	Susceptibility to HIV infection	HLA-C KIR3DL1	1.35e-03	16	101	2	cv:C1836230
Disease	basophil count, eosinophil count	HLA-B ARID5A KANSL3 MEIOSIN CLEC16A	1.46e-03	241	101	5	EFO_0004842, EFO_0005090
Disease	parental longevity	ANK2 HLA-B HLA-C RGS12 CEP350 PTPRD IQCE	1.57e-03	494	101	7	EFO_0007796
Disease	diastolic blood pressure, systolic blood pressure	CACNB2 ANK2 RGS12 CEP350 KIAA1671 LNX1 TAL1 CLEC16A	2.15e-03	670	101	8	EFO_0006335, EFO_0006336
Disease	COVID-19 (is_implicated_in)	HLA-B HLA-C	2.33e-03	21	101	2	DOID:0080600 (is_implicated_in)
Disease	Antimigraine preparation use measurement	RUNX1T1 MEF2D	2.33e-03	21	101	2	EFO_0009939
Disease	Precursor B-cell lymphoblastic leukemia	HLA-C AUTS2	2.33e-03	21	101	2	C1292769
Disease	neutrophil count	MAGI1 HIVEP1 HLA-B HLA-C ABCC5 CIT CBS MEF2D GTF3C1 PLCB1 LNX1 MYRF	2.70e-03	1382	101	12	EFO_0004833
Disease	Colorectal Carcinoma	CACNB2 PMS2 ANK2 ABCC5 RUNX1T1 PTPRD TNS4 CAMSAP2	2.86e-03	702	101	8	C0009402
Disease	unipolar depression, response to selective serotonin reuptake inhibitor	CBX4 PDZD2	3.05e-03	24	101	2	EFO_0003761, EFO_0005658
Disease	Brugada Syndrome (disorder)	CACNB2 ANK2	3.05e-03	24	101	2	C1142166
Disease	diacylglycerol 34:1 measurement	PYHIN1 COBL	3.05e-03	24	101	2	EFO_0010352
Disease	malaria (is_implicated_in)	CBS KIR3DL1	3.05e-03	24	101	2	DOID:12365 (is_implicated_in)
Disease	neuroimaging measurement, brain volume measurement	CACNB2 ARHGEF11 JPH1 MAST4 LNX1	3.07e-03	286	101	5	EFO_0004346, EFO_0006930
Disease	response to anticonvulsant	CACNB2 ANK2 SLC27A6	3.14e-03	85	101	3	GO_0036277
Disease	Autism Spectrum Disorders	GPR50 CHD2 NLGN3	3.14e-03	85	101	3	C1510586
Disease	diet measurement	HLA-B MFSD6 LAMA2 CHD2 IGSF11 TEX15 RUNX1T1 CIT RGS7 AUTS2	3.20e-03	1049	101	10	EFO_0008111
Disease	osteonecrosis	RGS7 PTPRD	3.31e-03	25	101	2	EFO_0004259
Disease	migraine disorder, diastolic blood pressure	MEF2D NCOR2	3.31e-03	25	101	2	EFO_0006336, MONDO_0005277
Disease	inflammatory bowel disease (implicated_via_orthology)	MUC2 PDZD2	3.31e-03	25	101	2	DOID:0050589 (implicated_via_orthology)
Disease	Glioma	PMS2 HLA-B HLA-C	3.35e-03	87	101	3	C0017638

Protein segments in the cluster

Peptide	Gene	Start	Entry
KPHSPRAVSSPATHS	LINC00114	46	Q6XXX2
THPTEVLKPVSQHPR	ARID5A	346	Q03989
KSSSTEPSPHIHPVD	GVINP1	956	Q7Z2Y8
SAPERKSPSHHRQPS	ARHGEF11	21	O15085
QILDTHPTKPAPRTH	CAMTA2	211	O94983
TTPAHSPVLKHPAAK	AMOTL1	901	Q8IY63
TIKPHSVPSHTLPSH	ARHGEF7	586	Q14155
TLPSHPVTPSSKHAD	ARHGEF7	596	Q14155
VTDPETHKSTKAAHP	FXYD5	86	Q96DB9
EGKPHSDKRSTSHLP	CASP8AP2	201	Q9UKL3
RKATDHPHPSTPATA	CIT	1296	O14578
PHHSQSTFRKTSPAP	TNK2	91	Q07912
PKPSANSVTSPHSKE	CACNB2	246	Q08289
ERPSHTVDISSHKPP	RAB20	211	Q9NX57
SKSHAAEPVRSHPPA	IQCE	356	Q6IPM2
PTEPSSKTGNPRHLH	KIR2DS2	231	P43631
DVPKKTTHRPHPAAS	ANK2	1796	Q01484
TTHRPHPAASPSLKS	ANK2	1801	Q01484
HPAASPSLKSERHAP	ANK2	1806	Q01484
ERHAPGSPSPKTERH	ANK2	1816	Q01484
SAKTERHPPVSPSSK	ANK2	1836	Q01484
RHPPVSPSSKTEKHS	ANK2	1841	Q01484
EKHSPVSPSTKTERH	ANK2	1876	Q01484
VSHLHPELPKPRVSS	FAM47C	771	Q5HY64
EIAKSPHSTVPEHHP	NCOR2	1591	Q9Y618
PTEPSSKTGNPRHLH	KIR2DL2	231	P43627
PTEPSSKTGNPRHLH	KIR2DS4	231	P43632
QTHHLASPSVSVKPP	LRRC37A3	401	O60309
GHSTPPKRTIVSPKH	LRRC37A3	626	O60309
TRLKPPHKLHPNFTS	GLIPR1	81	P48060
PPDLHKSSPHGEKRA	MAGI1	1276	Q96QZ7
LLEHSRKITPPSSPH	KIAA1671	1051	Q9BY89
QTHHLASPSVSVKPP	LRRC37A2	401	A6NM11
GHSTPPKRTIVSPKH	LRRC37A2	626	A6NM11
QTHHLASPSVSVKPP	LRRC37A	401	A6NMS7
GHSTPPKRTIVSPKH	LRRC37A	626	A6NMS7
EPLHSEHPSKRPCTI	RUNX1T1	256	Q06455
RKEEPSPLNLSHHTP	ATXN1L	356	P0C7T5
TPPRSPEASPKHSHS	JPH1	461	Q9HDC5
TSHPKPTTGHIKPAT	GPR50	496	Q13585
PTTGHIKPATSHAEP	GPR50	501	Q13585
PTEPSSKSGNPRHLH	KIR3DL1	326	P43629
AEPPKTHVTHHPLSD	HLA-C	206	P10321
PSKPHCPHSSSTTKR	MUC2	4656	Q02817
TDHRKPLISPQTSHK	PDZD2	1911	O15018
SVEKRHSSHPSPAPV	AUTS2	846	Q8WXX7
SNTPKPLHPTITCHE	LNX1	491	Q8TBB1
ATKTVKHGAPSPSHP	NUP214	1071	P35658
PTEPSSKTGNPRHLH	KIR2DS3	231	Q14952
PKASIVPSTHHSTSP	LAMA2	2251	P24043
GSIHSARSHKEPPSP	PACS2	336	Q86VP3
PKIRPTTHPTNASHQ	MFSD6	161	Q6ZSS7
ADPPKTHVTHHPISD	HLA-B	206	P01889
APKDPPESHSLHRSS	MEIOSIN	421	C9JSJ3
TKDLHQPSLSPASPH	OSBPL8	56	Q9BZF1
RHTTPTPSSKHPFKA	FANCD2OS	21	Q96PS1
SALKPIRTTSKHQHP	ABCC5	86	O15440
KVPPPDTTHSSHITR	NLGN3	646	Q9NZ94
SVSRKPRPPHTHSYT	IGSF11	391	Q5DX21
EHEPSLSSRHKNPAP	BORCS6	101	Q96GS4
TVKHSQPKPFHSVPS	CARD6	951	Q9BX69
SGDTPTTPKHPKDSR	CABIN1	1921	Q9Y6J0
DPSKTPHPESHVTHN	GFY	236	I3L273
PSQKSPHDSKSPLDH	CHD2	1791	O14647
PHDSKSPLDHRSPLE	CHD2	1796	O14647
PLTAHSPHAHPETKK	CGNL1	256	Q0VF96
SPHAHPETKKTRPDV	CGNL1	261	Q0VF96
PIHHIPSRRSPAKTI	BCLAF1	291	Q9NYF8
PPPTDTTHATHRKAG	DNAJB12	61	Q9NXW2
PPVTVKDDRTSSPHS	COBL	906	O75128
HPKPSEASTTLPESH	PYHIN1	421	Q6K0P9
SPSHKKRAADERHPP	CBX4	291	O00257
SESPHHHTAPAKSPK	CBS	61	P35520
SSAPVHAPRSHSPVK	CEP350	556	Q5VT06
SGSPPKSPRTTVHDK	DNAJC4	101	Q9NNZ3
KPVAAHSESSSHKPR	MAST4	2181	O15021
HKDRSPDPSTLASPH	FAM167A-AS1	16	Q96KT0
LKRHHPSSPLPGSKT	KANSL3	626	Q9P2N6
HHRFSPSQPKLPISS	CCDC168	4836	Q8NDH2
PTEPSSKTGNPRHLH	KIR2DL1	231	P43626
KTKSRVPPTSPSDHQ	PRRT3	191	Q5FWE3
PKSIHRDHIESPKTP	CAMSAP2	1266	Q08AD1
PKHERGSPSHSKSPA	MED1	1441	Q15648
TTHPHISIKSEPVSP	MEF2D	431	Q14814
KSSIPNNKEIPSHHP	PTPRD	1301	P23468
PHHKPSIPDLCDSSS	MMP20	286	O60882
DIRSHSPTHTPTPET	RGS7	236	P49802
PITHTRQVPSKPIDH	RHNO1	36	Q9BSD3
HSSRKPTTSKFPHLT	RHNO1	81	Q9BSD3
SRPALEKPHPHEEAT	SH3D21	456	A4FU49
EEPAPKHTARSLHPA	TAL1	306	P17542
HTPPSHSAKLLAEPS	FOXN1	496	O15353
RTPSSPHKKFSPSHS	SETD5	1121	Q9C0A6
SPPQHRPKTPSASSH	SPATA31C1	1171	P0DKV0
AKKSLSHPSHSRPGP	SPTY2D1	341	Q68D10
PEPHSHRGTDRKLSP	SPATC1L	121	Q9H0A9
HHESITPPSRSPTKE	SLX4	1671	Q8IY92
KDSPHPKHSLTTRLV	C12orf50	236	Q8NA57
NITIHKPASSPHSKP	CLEC16A	771	Q2KHT3
EAREHPTVVPSHKSP	CLCC1	451	Q96S66
DRLPHLHSKSKPSTT	SPATA2	441	Q9UM82
PRKHAEPSSSPSKVS	USP6NL	586	Q92738
PGEPAKPKTSAHHAT	RGS12	1431	O14924
PGTPHSHTKPYVRSK	RPL18	156	Q07020
RTPHSPPLAKEHASS	TNS4	346	Q8IZW8
HTTTLTPKPPSQALH	PLCB1	866	Q9NQ66
LRHTTENKPHSPKTP	PMS2	426	P54278
KTTSVHHRLPVQPDP	ZNF133	626	P52736
EHKEPTLPSDSPRHL	TNK1	86	Q13470
RHTTENKPHSPKTPE	PMS2CL	41	Q68D20
HPRTTGSHPKSENKI	TEX15	2356	Q9BXT5
KLSTSPDEPVPRSHH	SLC27A6	196	Q9Y2P4
STEVEPKESPHPARH	TEX2	196	Q8IWB9
SANLRPKTQPHHSTP	GTF3C1	501	Q12789
PSESPQHIAHPERKS	ZFYVE26	616	Q68DK2
HHVTVSPLRTDSPKA	HIVEP1	566	P15822
HPSKKRKHSESPPST	MYRF	251	Q9Y2G1